Ville de Bou-Ismail



Aller au contenu

Menu principal:

HaYa Info

Dr S OUNZAIN > HaYa Info

Lien au Journal Suisse "L·ACTU" de l'Universite de Lausane

New InnoTREK grant awarded to Daniel Blessing

In response to the 2017 autumn call InnoTREK Mr. Daniel Blessing submitted an innovative project on the development of cardiac-specific vectors. Hosted in the experimental cardiology department at the University Hospital of Lausanne of Professor Thierry Pedrazzini the financial support of the InnoTREK grant allows the laureate to mature this technology towards a start-up project over the coming year.

Thierry Pedrazzini (left), Samir Ounzain (center), Daniel Blessing (right) © droits réservés

The vectors to be developed are intended to reinforce a therapeutic approach developed by Thierry Pedrazzini and Samir Ounzain to treat cardiac diseases with long non-coding RNAs.

Together they will drive forward their project “HaYa Therapeutics”, an innovative technology that consists in the development and testing of a first-in-class biopharmaceutical therapy to treat heart failure and that was recently distinguished as one of the Gold Winners of the MassChallenge 2017 Switzerland.

The InnoTREK grant, organized by the PACTT with the support of the FIT as part of the InnoPACTT fund, supports selected researchers of UNIL and CHUV who have the ambition to venture into the business world with their innovative projects. These successful projects are chosen in a competitive process from applications received during the two calls per year. Since the launch in 2013, 13 laureates of UNIL and CHUV have benefited from the InnoTREK grant.

Publié le 15 décembre 2017
par Jelena Cvetanovic - PACTT

Accueil | Editorial | Ville | Histoire | Education | Santé | Culture | Sport | Dr S OUNZAIN | Actualité - Info | BI - YouTube | Nous Contacter | Petites Annonces | Plan du site

Revenir au contenu | Revenir au menu